Top Markets
#1 Pleasing Gold Pleasing Gold +1,463.64%
#2 PulseChain PulseChain +59.45%
#3 BOOK OF MEME BOOK OF MEME +34.33%
#4 Merlin's Seal BTC Merlin's Seal BTC +32.88%
#5 Ontology Gas Ontology Gas +28.49%
#6 Unit Pump Unit Pump +24.72%
#7 Pump.fun Pump.fun +24.72%
#8 Nockchain Nockchain +22.61%
#9 Neiro Neiro +21.92%
#10 ConstitutionDAO ConstitutionDAO +20.25%
Coin of the day
Pleasing Gold Pleasing Gold
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Clasificación en acciones #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Precio por acción
$0.53499835
Capitalización bursátil
$40.24M
Cambio (1 día)
2.50%
Cambio (1 año)
-58.07%
País
JP
Comercio Chordia Therapeutics Inc. (190A)

Categoría

Healthcare
Historial del precio de la acción de Chordia Therapeutics Inc. (190A)
Precio más alto de cierre: $0.53 el 2026-08-01

Precio más bajo de cierre: $1.06 el 2024-06-01
Historial del precio de la acción de Chordia Therapeutics Inc. desde 2024 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 10.93%
2025 -61.05%
2024 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $546.54 38.59%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.71%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.98 416.85%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 7.04%
CH